SELECTIVE HYPOTHERMIA TO PROTECT THE HEART AND BRAIN

Information

  • Research Project
  • 6211220
  • ApplicationId
    6211220
  • Core Project Number
    R43HL067480
  • Full Project Number
    1R43HL067480-01
  • Serial Number
    67480
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/2000 - 24 years ago
  • Project End Date
    8/31/2001 - 23 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/2000 - 24 years ago
  • Budget End Date
    8/31/2001 - 23 years ago
  • Fiscal Year
    2000
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/30/2000 - 24 years ago
Organizations

SELECTIVE HYPOTHERMIA TO PROTECT THE HEART AND BRAIN

Stroke occurs in 1-6% of patients undergoing surgery. As many as three out of four patients demonstrate neurologic injury in the week following cardiopulmonary bypass (CPB) with one out of five patients exhibiting permanent neurobehavioral dysfunction. The most obvious etiologic factor appears to be emboli originating from the surgical field and the CPB circuit. We propose to protect the brain and heart during cardiac procedures by eliminating or redirecting emboli as well as minimizing the trauma caused by emboli that do reach the brain. Cerebral hypothermia is the most potent, established tool in achieving neuroprotection because it decreases blood flow and metabolism, thereby reducing embolization. Further, hypothermia reduces the size of ischemic lesions. However, systemic normothermia appears to offer several advantages to the patient; a shorter operative time with improved myocardial and respiratory outcome accompanied by a reduction in postoperative bleeding. Unfortunately, normothermic CPB may place the patient at risk for neurologic deficit. A CPB technique that allows for cerebral hypothermia and systemic normothermia may optimize clinical outcome. This study will develop methods and apparatus for differential perfusion of the aortic arch and corporeal circulations using a triple lumen catheter which will reduce cerebral embolization. PROPOSED COMMERCIAL APPLICATIONS: Over half of the 500,000 patients undergoing CPB last year in the USA had evidence of brain injury (l). The successful development of a method to reduce brain injury will have a major impact on patient outcome and health care resources. Unlike therapeutic interventions, a method of differential cerebral and corporeal perfusion using a multiple lumen catheter would be rapidly applicable to clinical CPB requiring only minimal training and adjunctive apparatus and be relatively inexpensive.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    97350
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:97350\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CARDEON CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    CUPERTINO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    95014
  • Organization District
    UNITED STATES